SLSN (Solesence) Accounts Payable & Accrued Expense : $14.43 Mil (As of Mar. 2025)

View and export this data going back to 1997. Start your Free Trial

What is Solesence Accounts Payable & Accrued Expense?

Solesence's quarterly accounts payable & accrued expense increased from Sep. 2024 ($9.77 Mil) to Dec. 2024 ($13.94 Mil) and increased from Dec. 2024 ($13.94 Mil) to Mar. 2025 ($14.43 Mil).

Solesence's annual accounts payable & accrued expense declined from Dec. 2022 ($7.33 Mil) to Dec. 2023 ($7.13 Mil) but then increased from Dec. 2023 ($7.13 Mil) to Dec. 2024 ($13.94 Mil).

Solesence Accounts Payable & Accrued Expense Historical Data

The historical data trend for Solesence's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Solesence Accounts Payable & Accrued Expense Chart

Solesence Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

2.61

4.39

7.33

7.13

13.94

Solesence Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															7.56	7.38	9.77	13.94	14.43

Solesence Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Solesence Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Solesence Inc (NAS:SLSN) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

1319 Marquette Drive, Romeoville, IL, USA, 60446

Website

https://www.solesence.com

Solesence Inc is a scientifically driven health care solutions company across beauty and life science categories, protecting skin from environmental aggressors and enhancing the aesthetic appeal of healthy products. The group is engaged in the beauty category that develops and manufactures clean, inclusive, mineral-based skincare and makeup products at the forefront of skin health. Its brands are Stress Defense, Kleair, and Bloom.

Executives

R Janet Whitmore	director
Kevin Cureton	officer: VP, Sales & Marketing & BD	1319 MARQUETTE DRIVE, ROMEOVILLE IL 60446
Bradford T Whitmore	10 percent owner	5215 OLD ORCHARD ROAD, SUITE 620, SKOKIE IL 60077
Jess Jankowski	officer: Chief Financial Officer
Mark E Miller	director	1319 MARQUETTE DR, ROMEOVILLE IL 60446
Strandler, Llc	10 percent owner	401 3RD STREET, #9, RAPID CITY SD 57701
Laura M Beres	director	1319 MARQUETTE DR, ROMEOVILLE IL 60446
Jaime Escobar	officer: Chief Financial Officer	1319 MARQUETTE DRIVE, ROMEOVILLE IL 60446
Frank Cesario	officer: Chief Financial Officer	C/O ISCO INTERNATIONAL INC, 451 KIGSTON COURT, MT PROSPECT IL 60056
James A Henderson	director	301 WASHINGTON ST, COLUMBUS IN 47201
George A Vincent	director	C/O NANOPHASE TECHNOLOGIES, 1319 MARQUETTE DRIVE, ROMEOVILLE IL 60446
Spurgeon Corp	10 percent owner	407 S. THIRD STREET, SUITE 230, GENEVA IL 60134
W Edwin Tyler	director	ONE NORTH WACKER DRIVE, SUITE 4200, CHICAGO IL 60606
Nancy Baldwin	officer: VP Human Resources & IT	1319 MARQUETTE DRIVE, ROMEOVILLE IL 60446
Patrick G Murray	officer: VP Research & Development	1319 MARQUETTE DRIVE, ROMEOVILLE IL 60446